Clinical trial
Monitoring Outpatient Blood VolumE in Heart Failure
NCT04660396 is registered in ClinicalTrials.gov with Daxor Corporation as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Monitoring Outpatient Blood VolumE in Heart Failure
- Lead sponsor
- Daxor Corporation
- Phase
- Observational
- Overall status
- Completed
- Start date
- September 16, 2021
- Completion date
- July 30, 2022
- Enrollment
- 15 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.